ANP 235, which has not yet been given an approved name, is sold in this country by Lloyd Anphar. It has been advertised in some of the medical press quite soberly but not very informatively, featuring eight ‘facts’. One of these is that the reference list now exceeds 150 publications. Though this appears to be true, the information is of no value to medical practitioners unless it is critically evaluated. The assertion that many of the papers are adequate double-blind trials is debatable. The manufacturer's list contains only favourable reports and almost all the papers are in French, Italian and German. At our request they very kindly selected ten which they themselves regard as the most impressive. We have also consulted a more extensive selection which they supplied in translation.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.